# Neurodegenerative disease research and Italian ALS care

> Developing situation record from CLSTR: https://clstr.news/situations/neurodegenerative-disease-research-developments
> Updated: 2026-11-18T17:43:00.000Z. Sources: 45. Developments: 3.

Scientific research into neurodegenerative diseases, including ALS, Parkinson’s, and Alzheimer’s, is advancing through new imaging technologies and cellular discoveries. At the American Neurological Association’s 151st Annual Meeting, experts noted that super-resolution microscopy and artificial intelligence enable real-time observation of molecular disruptions and neuronal stress. Additionally, researchers at Nagoya University identified a natural cellular defense mechanism in human neuron cultures and mice that may prevent the aggregation of the TDP-43 protein. Further progress in ALS research includes clinical trials testing molecules to reduce motor neuron degradation or nerve hyperexcitability. Researchers are also utilizing organ-on-a-chip microdevices with patient-derived motor neurons to study disease mechanisms and identify early anomalies in neuron-muscle communication. Recent developments emphasize the role of genetic mutations and RNA-targeted therapies. During the ‘La promessa 2026’ event, researchers highlighted Italy’s leading role in identifying genetic alterations through collaborations with American scientists. Medical experts, including Neil Shneider and Piera Pasinelli, noted a shift toward targeting underlying molecular mechanisms rather than just slowing progression. Specific progress includes the use of the drug tofersen for patients with the Sod1 gene mutation, alongside ongoing research into the Fus and Tardbp genes. During the ‘La Promessa 2026’ marathon event, medical professionals such as Neil Shneider and Mario Sabatelli discussed the potential of RNA-targeted therapies, specifically antisense oligonucleotides (ASOs), to modify the production of abnormal proteins for personalized treatment. Experts noted that the Tardbp gene is particularly prevalent in Italy and France. Advocates from the Italian Association for Amyotrophic Lateral Sclerosis (Aisla), including Alberto Fontana and Pina Esposito, emphasized the need for faster institutional responses. Esposito requested that the Ministry of Disability extend the 15-day evaluation period for ALS patients to ensure clinical and regulatory consistency.

## Claims

- RNA-targeted therapies can modify the production of abnormal proteins involved in neurodegenerative diseases. (reported by 3 sources)
- Tofersen has shown results in patients with the Sod1 gene mutation. (reported by 3 sources)
- Research is ongoing regarding the Tardbp gene mutation. (reported by 3 sources)
- The Tardbp gene mutation is particularly widespread in Italy and France. (reported by 3 sources)
- Antisense oligonucleotides (ASO) are personalized therapies that act on RNA. (reported by 3 sources)

## Timeline

### 2026-11-18: Italy healthcare sector faces debates over nursing, research, and funding

Italy's healthcare sector is navigating debates over nursing professionalization, ALS research advancements, and significant funding concerns regarding elderly vision care and territorial services.

43 sources. https://clstr.news/cluster/italy-healthcare-sector-faces-debates-over-nursing-research-and-funding

### 2026-11-13: ALS research shows progress in clinical trials and diagnostic technology

ALS research is seeing advancements in clinical trials targeting motor neuron degradation and the use of organ-on-a-chip technology to better understand early disease mechanisms.

2 sources. https://clstr.news/cluster/als-research-shows-progress-in-clinical-trials-and-diagnostic-technology

### 2026-10-20: Neurological disease research advances through microscopy and cellular defense discoveries

Advancements in super-resolution microscopy and the discovery of a natural cellular defense against TDP-43 protein aggregation are providing new insights into treating neurodegenerative diseases like ALS.

2 sources. https://clstr.news/cluster/neurological-disease-research-advances-through-microscopy-and-cellular-defense-discoveries

---
Cite as: Neurodegenerative disease research and Italian ALS care. CLSTR, https://clstr.news/situations/neurodegenerative-disease-research-developments
